Results 11 to 20 of about 95,123 (282)

BRCA1 Antibodies Matter [PDF]

open access: yesInternational Journal of Biological Sciences, 2021
Breast cancer susceptibility gene 1 (BRCA1) encodes a tumor suppressor that is frequently mutated in familial breast and ovarian cancer patients. BRCA1 functions in multiple important cellular processes including DNA damage repair, cell cycle checkpoint activation, protein ubiquitination, chromatin remodeling, transcriptional regulation, as well as R ...
Yang, Jing   +5 more
openaire   +2 more sources

BRCA1 and BRCA2 [PDF]

open access: yesCurrent Biology, 2000
Bertwistle D, Ashworth A: Functions of the BRCA1 and BRCA2 genes.Curr Opin Genet Dev 1998, 8:14-20.Rahman N, Stratton MR: The genetics of breast cancer susceptibility.Annu Rev Genet 1998, 32:95-121.Hongbing Z, Tombline G, Weber BL: BRCA1, BRCA2, and DNA damage response: collision or collusion?Cell 1998, 92:433-436.
Bertwistle, David, Ashworth, Alan
openaire   +2 more sources

A systematic review on the association between ovarian and prostate cancer with BRCA1 and BRCA2 gene

open access: yesСибирский онкологический журнал, 2023
Background. BRCA1 and BRCA2 were discussed as the basis of inherited adenocarcinoma and breast and ovarian malignancy. Ovarian cancer is uncommon in women below 40 years of age, and prostate cancer mainly occurs in older men cause 90 % in those above ...
Sarpparajan Chitra Veena   +2 more
doaj   +1 more source

Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1 [PDF]

open access: yesOncogene, 2001
Unregulated expression of wild-type BRCA1 (wtBRCA1) confers an altered phenotype in cultured human prostate cancer cells, characterized by chemosensitivity, susceptibility to apoptosis, decreased DNA repair activity, and alterations of key cell regulatory proteins.
S, Fan   +5 more
openaire   +2 more sources

ОСОБЕННОСТИ ЭКСПРЕССИИ РЕЦЕПТОРОВ ЭСТРОГЕНОВ, ПРОГЕСТЕРОНА И АНДРОГЕНОВ ПРИ НАСЛЕДСТВЕННЫХ И СПОРАДИЧЕСКИХ ОВАРИАЛЬНЫХ КАРЦИНОМАХ

open access: yesŽurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2022
Введение. Овариальные карциномы – сложное гетерогенное заболевание с разнообразием клинико-морфологических форм. В большинстве случаев опухоли яичников экспрессируют эстрогеновые (РЭ), прогестероновые (РП) или андрогеновые (РА) рецепторы, но, в отличие ...
А. L. Savаnevich   +2 more
doaj   +1 more source

BRCA1-BARD1: the importance of being in shape

open access: yesMolecular & Cellular Oncology, 2019
The breast cancer type-1 susceptibility protein (BRCA1) contributes to genome integrity through homologous recombinational DNA repair and by protecting stalled replication forks from nucleolytic degradation.
Manuel Daza-Martin   +2 more
doaj   +1 more source

BRCA1 16 years later: DNA damage‐induced BRCA1 shuttling [PDF]

open access: yesThe FEBS Journal, 2010
The tumor suppressor, breast cancer susceptibility gene 1 (BRCA1), plays an integral role in the maintenance of genome stability and, in particular, the cellular response to DNA damage. Here, the emerging role of BRCA1 in nonhomologous end‐joining‐mediated DNA repair following DNA damage will be reviewed, as well as the activation of apoptotic pathways.
Eddy S, Yang, Fen, Xia
openaire   +2 more sources

The prognostic significance of BRCA1 gene expression in patients with breast cancer

open access: yesУспехи молекулярной онкологии, 2019
Background. Nowadays, BRCA-associated breast cancer occupies a special position in the choice of treatment strategy. Although, the drug treatment of such patients was almost the same as the treatment of sporadic disease.
M. M. Tsyganov   +5 more
doaj   +1 more source

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery

open access: yesУспехи молекулярной онкологии, 2015
5–10 % of breast cancer cases are hereditary, 30 % of them are caused by BRCA1 and BRCA2 mutations (breast / ovarian cancer syndrome). Average cumulative risks of breast and ovarian cancer in BRCA1 mutation carriers run up to 87 % and 44 ...
L. N. Lyubchenko   +8 more
doaj   +1 more source

BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer

open access: yesУспехи молекулярной онкологии, 2018
Background. Most modern studies are limited to the study of only germline mutations of the BRCA1 gene (most often 5382insC). And there are very few works that characterize the different somatic changes in the BRCA1 gene in the tumor, in particular the ...
M. M. Tsyganov   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy